Researchers report that patients treated for treatment-resistant depression with esketamine NS (nasal spray), a form of ketamine, achieve better and more durable outcomes than similar patients treated with […]
Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up […]
Persons with an evening ‘chronotype”’ (going to bed late and waking up late), have a 19 percent increased risk of diabetes compared to those with a morning chronotype, […]
Co-users of tobacco and cannabis report more anxiety and depression than users of tobacco only and users of neither substance. Researchers reported these findings in PLOS ONE on […]
Among children suspected of having sinusitis, a swabbing for three types of bacteria can determine whether antibiotics are likely to be an effective treatment. The finding were published […]
In the first randomized trial to study the efficacy of opioid pain relievers for the treatment of acute lower back and neck pain for up to one year, […]
In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug. Tadalafil […]
Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of […]
Among persons diagnosed with type 2 diabetes, consumption of tea, coffee or water rather than sugary drinks has been linked to lower rates of early death due to […]
People with hearing loss who do not use hearing aids appear to be at a higher risk of developing dementia than people with hearing loss who use hearing […]
New research shows that patients with newly diagnosed type 2 diabetes who received treatment with the diabetes drug pioglitazone were less likely to go on to develop dementia […]
Two doses of mRNA covid-19 vaccine during pregnancy show significant efficacy against delta and omicron infection in infants under six-months old. They also reduce hospital admission for covid-19 […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
